SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001554795-13-000610
Filing Date
2013-10-18
Accepted
2013-10-18 16:40:14
Documents
4
Period of Report
2013-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A gnbt101513form10ka.htm 10-K/A 373100
2 EXHIBIT 31.1 gnbt101513exh311.htm EX-31.1 15578
3 EXHIBIT 31.2 gnbt101513exh312.htm EX-31.2 12615
4 EXHIBIT 32 gnbt101513exh32.htm EX-32 6714
  Complete submission text file 0001554795-13-000610.txt   409043
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 000-25169 | Film No.: 131159789
SIC: 2834 Pharmaceutical Preparations